Pramiconazole: Difference between revisions
Content deleted Content added
Carlo Banez (talk | contribs) stub |
image, IUPAC name |
||
| Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| IUPAC_name = 1-[4-[4-[4-<nowiki>[[</nowiki>(2''R'',4S)-2-(2,4-Difluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-3-propan-2-ylimidazolidin-2-one |
|||
| IUPAC_name = |
|||
| image = |
| image = Pramiconazole.png |
||
| width = |
| width = |
||
| image2 = |
| image2 = |
||
Revision as of 13:50, 4 May 2008
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C35H39F2N7O4 |
| Molar mass | 659.725 g/mol g·mol−1 |
Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections.
It is developed by Barrier Therapeutics.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |